Novartis’s PR nightmare

KEY SUMMARY: “Any formal lobbying by companies of Congress or Cabinet agencies must be reported and disclosed quarterly. Novartis’s outreach to Cohen — who isn’t part of the administration, isn’t a registered lobbyist and isn’t an expert in the telecommunications or pharmaceutical industriesfalls into a secretive, gray area of influence activity that ethics experts charge is ripe for abuse.” Continue reading